Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ASCO GU 2026: Updates in bladder cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in bladder cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

ASCO GU 2026: Updates in metastatic prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in metastatic prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

ASCO GU 2026: Updates in localised prostate cancer

Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina
ASCO GU 2026: Updates in localised prostate cancer ( Dr María Natalia Gandur Quiroga - Instituto de Oncología 'Ángel H. Roffo', Universidad de Buenos Aires, Argentina )
17 Mar 2026

Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular germ cell tumours during active surveillance

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,
Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular germ cell tumours during active surveillance ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )
6 Mar 2026

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia,
Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia, )
6 Mar 2026

Evaluation and definition of response and progression from trials to clinical practice

Dr Andrew Armstrong - Duke University, Durham, North Carolina
Evaluation and definition of response and progression from trials to clinical practice ( Dr Andrew Armstrong - Duke University, Durham, North Carolina )
6 Mar 2026

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA
FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )
6 Mar 2026

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer

Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA
Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer ( Dr Matthew Galsky - Icahn School of Medicine at Mount Sinai, New York, USA )
6 Mar 2026

Latest in bladder cancer from the second half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Enrique Grande
Latest in bladder cancer from the second half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Enrique Grande )
25 Nov 2025

Do all hormone sensitive prostate cancers need triplet therapy?

Dr Deepak Dabkara - Tata Medical Center, Kolkata, India
Do all hormone sensitive prostate cancers need triplet therapy? ( Dr Deepak Dabkara - Tata Medical Center, Kolkata, India )
7 Nov 2025

Panel Discussion: Case based discussions muscle invasive bladder cancer

Panelists: Dr Madhav Tiwari, Dr Tushar Dani, Dr Jaswant Jain, Dr Suneel Kaushik, Dr Pradeep Chandrakar, Dr Puneet Seth, Dr Satvik Khaddar, Dr Azam Nawaz, Dr Aparna Sreevatsa, Dr Gaurav Gupta
Panel Discussion: Case based discussions muscle invasive bladder cancer ( Panelists: Dr Madhav Tiwari, Dr Tushar Dani, Dr Jaswant Jain, Dr Suneel Kaushik, Dr Pradeep Chandrakar, Dr Puneet Seth, Dr Satvik Khaddar, Dr Azam Nawaz, Dr Aparna Sreevatsa, Dr Gaurav Gupta )
7 Nov 2025

Choosing Wisely for genitourinary cancers

Dr Vanita Noronha - Tata Memorial Hospital, Mumbai. India
Choosing Wisely for genitourinary cancers ( Dr Vanita Noronha - Tata Memorial Hospital, Mumbai. India )
6 Nov 2025